Click Chemistry-Mediated Functionalization of Engineered Oncolytic Extracellular Vesicles Promotes Coordinated T- and B-Cell Antitumor Immunity
Nano Letters · 04.11.2026 · 26 (43) · 14968-14978
DOI: 10.1021/acs.nanolett.6c03597 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, online erschienen am 22.10.2026. Verfasst von Wenmo Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun130012, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, B-Lymphocytes, Oncolytic Viruses, T-Lymphocytes. Die Arbeit nennt 34 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Fundamental Research Funds for the Central Universities, ?Medicine + X? Interdisciplinary Innovation Team of Norman Bethune Health Science Center of Jilin University.
Abstract (Originalsprache)
Engineered extracellular vesicles (EVs) are promising therapeutic carriers for cancer treatment, but preserving intrinsic therapeutic activity while incorporating multiple immunomodulatory functions remains a challenge. Here, we developed a modular engineering strategy that combines the genetic engineering of EV-producing cells with bioorthogonal click chemistry to construct multifunctional oncolytic extracellular vesicles (OEVs). Azide-functionalized OEVs were generated from CD40L-expressing cells infected with a capsid-engineered oncolytic adenovirus. A toll-like receptor 9 (TLR9) agonist was subsequently conjugated to the OEV surface through click chemistry, integrating immune stimulation while retaining the oncolytic activity. The engineered OEVs efficiently infected tumor cells, induced antigen-presenting cell activation, enhanced intratumoral CD8+ T-cell responses, promoted B-cell activation and tumor-specific antibody production, and improved the therapeutic efficacy of the immune checkpoint blockade. These findings demonstrated that combining genetic engineering with bioorthogonal chemistry provided a strategy for constructing multifunctional oncolytic EVs with coordinated cytotoxic and immunomodulatory activities, offering an approach to next-generation cancer immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun130012, China.
- Key Laboratory for Molecular Enzymology and Engineering, The Ministry of Education, School of Life Sciences, Jilin University, Changchun130012, China.
ORCID-Profile: Bin Yu
Förderung
- China Postdoctoral Science Foundation
- Fundamental Research Funds for the Central Universities
- ?Medicine + X? Interdisciplinary Innovation Team of Norman Bethune Health Science Center of Jilin University
- National Natural Science Foundation of China (NSFC)
- “Medicine + X” Interdisciplinary Innovation Team of Norman Bethune Health Science Center of Jilin University
Zitieren
APA
Liu, W., Yang, Y., Wang, L., Zhou, H., Li, F., Zhang, C., Zhang, N., Liu, X., Yu, J., Zheng, K., Yu, B., & Yu, X. (2026). Click Chemistry-Mediated Functionalization of Engineered Oncolytic Extracellular Vesicles Promotes Coordinated T- and B-Cell Antitumor Immunity. Nano Letters, 26(43), 14968-14978. https://doi.org/10.1021/acs.nanolett.6c03597
Vancouver
Liu W, Yang Y, Wang L, Zhou H, Li F, Zhang C, et al. Click Chemistry-Mediated Functionalization of Engineered Oncolytic Extracellular Vesicles Promotes Coordinated T- and B-Cell Antitumor Immunity. Nano Letters. 2026;26(43):14968-14978. doi:10.1021/acs.nanolett.6c03597
BibTeX
@article{Liu2026,
author = {Liu, Wenmo and Yang, Ying and Wang, Liying and Zhou, Hong and Li, Fangshen and Zhang, Chunhe and Zhang, Nan and Liu, Xinyao and Yu, Jiahao and Zheng, Kaiwen and Yu, Bin and Yu, Xianghui},
title = {Click Chemistry-Mediated Functionalization of Engineered Oncolytic Extracellular Vesicles Promotes Coordinated T- and B-Cell Antitumor Immunity},
journal = {Nano Letters},
year = {2026},
volume = {26},
number = {43},
pages = {14968--14978},
doi = {10.1021/acs.nanolett.6c03597}
}
EUVIMED